Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study (Q72835508)
Jump to navigation
Jump to search
scientific article published on 01 January 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study |
scientific article published on 01 January 1994 |
Statements
Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. A Lyon-Marseille-Curie-east of France Group Study (English)
Michon J
Négrier S
Coze C
Mathiot C
Frappaz D
Oskam R
Pacquement H
Quintana E
Bouffet E
1 January 1994